Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in the KLHL6 gene in diffuse large B-cell lymphoma, the most common cancer of the lymphatic system.
Jun 18, 2024
0
0
Biomedical engineers at Duke University have developed a method to deliver drugs to specific types of neurons throughout the brain. This new approach, which was tested in mice, was 100 times more precise than existing methods ...
Jun 18, 2024
0
18
Investigators from Northwestern University Feinberg School of Medicine and The University of Texas MD Anderson Cancer Center have discovered that using a novel drug to target the STING pathway in glioblastoma reprogrammed ...
Jun 18, 2024
0
6
A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant ...
Jun 17, 2024
0
23
University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalized cancer treatments which could be more effective at preventing patient relapse.
Jun 17, 2024
0
3
A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago Medicine's David T. ...
Jun 17, 2024
0
1
Sjögren's disease primarily affects the salivary and lacrimal glands, resulting in tissue inflammation characterized by the formation of tertiary lymphoid structures (TLS), and a loss of glandular function—resulting in ...
Jun 17, 2024
0
5
There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society.
Jun 17, 2024
0
0
Researchers from the Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA), Centers for Medicare & Medicaid Services (CMS), and ...
Jun 17, 2024
0
0
It's welcome news for Alzheimer's patients and their families: A Food and Drug Administration advisory panel unanimously recommended approval for Eli Lilly & Co.'s treatment donanemab. If given the agency's green light later ...
Jun 17, 2024
0
4
